Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Sho Inomata"'
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Background The development of systemic chemotherapy including immune checkpoint inhibitors (ICIs) has provided patients with unresectable advanced non-small cell lung cancer (NSCLC) an opportunity to undergo surgical intervention after initi
Externí odkaz:
https://doaj.org/article/de5b9f677aec4bc1879e617070eebf81
Autor:
Sho Inomata, Yuki Matsumura, Yasuyuki Kobayashi, Hikaru Yamaguchi, Masayuki Watanabe, Yuki Ozaki, Satoshi Muto, Naoyuki Okabe, Yutaka Shio, Hiroyuki Suzuki
Publikováno v:
Thoracic Cancer, Vol 13, Iss 21, Pp 3076-3079 (2022)
Abstract Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH), a rare condition, is characterized by pathological proliferation of neuroendocrine cells. Some of them are localized to the airway mucosa, and others locally infiltrate
Externí odkaz:
https://doaj.org/article/3230c1a58b1e403c91e1417cce836bc1
Autor:
Hironori Takagi, Yuki Matsumura, Mitsuro Fukuhara, Sho Inomata, Hikaru Yamaguchi, Masayuki Watanabe, Yuki Ozaki, Satoshi Muto, Naoyuki Okabe, Yutaka Shio, Haruka Saito, Hayato Tanabe, Michio Shimabukuro, Hiroyuki Suzuki
Publikováno v:
Cancer Reports, Vol 5, Iss 11, Pp n/a-n/a (2022)
Abstract Background Carcinoid tumors can on rare occasions ectopically produce adrenocorticotropic hormone (ACTH), causing Cushing's syndrome, and patients could become immunocompromised. Care must therefore be taken regarding infectious complication
Externí odkaz:
https://doaj.org/article/330a7ba6e2ae4df78be43d37861e681f
Autor:
Yuki Matsumura, Sho Inomata, Hikaru Yamaguchi, Hayato Mine, Hironori Takagi, Masayuki Watanabe, Yuki Ozaki, Takumi Yamaura, Mitsuro Fukuhara, Satoshi Muto, Naoyuki Okabe, Takeo Hasegawa, Yutaka Shio, Hiroyuki Suzuki
Publikováno v:
Thoracic Cancer, Vol 12, Iss 15, Pp 2225-2228 (2021)
Abstract Echinoderm microtubule‐associated protein‐like 4‐anaplastic lymphoma kinase (EML4‐ALK) rearrangements are found in ~ 5% of patients with non‐small cell lung cancer (NSCLC). Several tyrosine kinase inhibitors (TKIs) have been develo
Externí odkaz:
https://doaj.org/article/d20fba4120ae4582806957053ea8e184
Autor:
Satoshi Muto, Akio Enta, Yoshiyuki Maruya, Sho Inomata, Hikaru Yamaguchi, Hayato Mine, Hironori Takagi, Yuki Ozaki, Masayuki Watanabe, Takuya Inoue, Takumi Yamaura, Mitsuro Fukuhara, Naoyuki Okabe, Yuki Matsumura, Takeo Hasegawa, Jun Osugi, Mika Hoshino, Mitsunori Higuchi, Yutaka Shio, Kazuyuki Hamada, Hiroyuki Suzuki
Publikováno v:
Biomedicines, Vol 11, Iss 1, p 190 (2023)
Lung cancer is the leading cause of cancer-related deaths worldwide. The standard of care for advanced non-small-cell lung cancer (NSCLC) without driver-gene mutations is a combination of an anti-PD-1/PD-L1 antibody and chemotherapy, or an anti-PD-1/
Externí odkaz:
https://doaj.org/article/50d16f23ec2147a9aeafd37d121f5703
Autor:
Yuki Matsumura, Sho Inomata, Hikaru Yamaguchi, Masayuki Watanabe, Yuki Ozaki, Satoshi Muto, Naoyuki Okabe, Yutaka Shio, Yasuhiko Tsukada, Hiroyuki Suzuki
Publikováno v:
Annals of Thoracic Surgery Short Reports. 1:91-93
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d118e57ef0e998cd3286775503be8167
https://doi.org/10.1016/j.atssr.2022.11.006
https://doi.org/10.1016/j.atssr.2022.11.006
Autor:
Hikaru Yamaguchi, Satoshi Muto, Sho Inomata, Masayuki Watanabe, Yuki Ozaki, Naoyuki Okabe, Yuki Matsumura, Yutaka Shio, Hiroyuki Suzuki
Publikováno v:
Haigan. 62:103-106
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c176bbc89c5267794280ba6c0d0cdbb
https://doi.org/10.2482/haigan.62.103
https://doi.org/10.2482/haigan.62.103
Autor:
Hiroyuki Suzuki, Sho Inomata, Hikaru Yamaguchi, Hayato Mine, Hironori Takagi, Yuki Ozaki, Masayuki Watanabe, Takuya Inoue, Mitsuro Fukuhara, Takumi Yamaura, Satoshi Muto, Naoyuki Okabe, Yuki Matsumura, Takeo Hasegawa, Jun Osugi, Mika Hoshino, Mitsunori Higuchi, Yutaka Shio
Publikováno v:
Haigan. 61:919-923
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::293fc51c3938a4a289146ab8eab7afa4
https://doi.org/10.2482/haigan.61.919
https://doi.org/10.2482/haigan.61.919
Autor:
Hironori Takagi, Jun Osugi, Mika Hoshino, Yuki Matsumura, Hiroyuki Suzuki, Hikaru Yamaguchi, Hayato Mine, Mitsuro Fukuhara, Masayuki Watanabe, Yutaka Shio, Takuya Inoue, Mitsunori Higuchi, Sho Inomata, Yuki Ozaki, Takumi Yamaura, Takeo Hasegawa, Satoshi Muto, Naoyuki Okabe
Publikováno v:
Cancer Immunology, Immunotherapy. 71:1129-1137
The presence of tertiary lymphoid structure (TLS) in tumor tissues has been reported to be a factor associated with a good prognosis in several types of cancers. However, the relationship between TLS formation and peripheral blood findings remains un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e24b9e556941dfec0b1e1ea11076c516
https://doi.org/10.1007/s00262-021-03067-3
https://doi.org/10.1007/s00262-021-03067-3
Autor:
Hiroyuki Suzuki, Hikaru Yamaguchi, Hironori Takagi, Takeo Hasegawa, Sho Inomata, Naoyuki Okabe, Takumi Yamaura, Yutaka Shio, Masayuki Watanabe, Yuki Ozaki, Mitsuro Fukuhara, Satoshi Muto, Yuki Matsumura, Hayato Mine
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 12, Iss 15, Pp 2225-2228 (2021)
Thoracic Cancer, Vol 12, Iss 15, Pp 2225-2228 (2021)
Echinoderm microtubule‐associated protein‐like 4‐anaplastic lymphoma kinase (EML4‐ALK) rearrangements are found in ~ 5% of patients with non‐small cell lung cancer (NSCLC). Several tyrosine kinase inhibitors (TKIs) have been developed for t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baba5b8889cbbd4217def325140455a0
https://doi.org/10.1111/1759-7714.14058
https://doi.org/10.1111/1759-7714.14058